These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32326325)

  • 1. Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y
    Braza-Boïls A; Barwari T; Gutmann C; Thomas MR; Judge HM; Joshi A; Pechlaner R; Shankar-Hari M; Ajjan RA; Sabroe I; Storey RF; Mayr M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs as novel biomarkers for platelet activation.
    Willeit P; Zampetaki A; Dudek K; Kaudewitz D; King A; Kirkby NS; Crosby-Nwaobi R; Prokopi M; Drozdov I; Langley SR; Sivaprasad S; Markus HS; Mitchell JA; Warner TD; Kiechl S; Mayr M
    Circ Res; 2013 Feb; 112(4):595-600. PubMed ID: 23283721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet MicroRNA 365-3p Expression Correlates with High On-treatment Platelet Reactivity in Coronary Artery Disease Patients.
    Chen YC; Lin FY; Lin YW; Cheng SM; Chang CC; Lin RH; Chuang CL; Sheu JS; Chen SM; Tsai CS
    Cardiovasc Drugs Ther; 2019 Apr; 33(2):129-137. PubMed ID: 30783954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report.
    Chyrchel B; Totoń-Żurańska J; Kruszelnicka O; Chyrchel M; Mielecki W; Kołton-Wróż M; Wołkow P; Surdacki A
    Platelets; 2015; 26(6):593-7. PubMed ID: 25350775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia.
    Kiers D; van der Heijden WA; van Ede L; Gerretsen J; de Mast Q; van der Ven AJ; El Messaoudi S; Rongen GA; Gomes M; Kox M; Pickkers P; Riksen NP
    Thromb Haemost; 2017 Aug; 117(9):1798-1807. PubMed ID: 28692111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of MicroRNAs and YRNAs With Platelet Function.
    Kaudewitz D; Skroblin P; Bender LH; Barwari T; Willeit P; Pechlaner R; Sunderland NP; Willeit K; Morton AC; Armstrong PC; Chan MV; Lu R; Yin X; Gracio F; Dudek K; Langley SR; Zampetaki A; de Rinaldis E; Ye S; Warner TD; Saxena A; Kiechl S; Storey RF; Mayr M
    Circ Res; 2016 Feb; 118(3):420-432. PubMed ID: 26646931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNAs as promising biomarkers of platelet activity in antiplatelet therapy monitoring.
    Krammer TL; Mayr M; Hackl M
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus.
    Fejes Z; Póliska S; Czimmerer Z; Káplár M; Penyige A; Gál Szabó G; Beke Debreceni I; Kunapuli SP; Kappelmayer J; Nagy B
    Thromb Haemost; 2017 Feb; 117(3):529-542. PubMed ID: 27975100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Course of platelet miRNAs after cessation of P2Y12 antagonists.
    Jäger B; Stojkovic S; Haller PM; Piackova E; Kahl BS; Andric T; Vargas KG; Wojta J; Huber K
    Eur J Clin Invest; 2019 Aug; 49(8):e13149. PubMed ID: 31172515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
    Schrottmaier WC; Kral JB; Badrnya S; Assinger A
    Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel reduces lipopolysaccharide-induced inflammation and neutrophil-platelet aggregates in an experimental endotoxemic model.
    Wang XL; Deng HF; Li T; Miao SY; Xiao ZH; Liu MD; Liu K; Xiao XZ
    J Biochem Mol Toxicol; 2019 Apr; 33(4):e22279. PubMed ID: 30537341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensified P2Y12 inhibition for high-on treatment platelet reactivity.
    Mshelbwala FS; Hugenberg DW; Kreutz RP
    J Thromb Thrombolysis; 2020 Oct; 50(3):619-627. PubMed ID: 32152791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.
    Gasecka A; Nieuwland R; Budnik M; Dignat-George F; Eyileten C; Harrison P; Huczek Z; Kapłon-Cieślicka A; Lacroix R; Opolski G; Pluta K; van der Pol E; Postuła M; Leroyer A; Siljander P; Sturk A; Filipiak KJ
    Platelets; 2020; 31(1):26-32. PubMed ID: 30585111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis favors high-on-clopidogrel platelet reactivity.
    Akinosoglou K; Perperis A; Theodoraki S; Alexopoulos D; Gogos C
    Platelets; 2018 Jan; 29(1):76-78. PubMed ID: 28635374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is platelet inhibition correlated with time from last intake on P2Y12 blockers after an acute coronary syndrome? A pilot study.
    Deharo P; Quilici J; Bonnet G; Grosdidier C; Morange P; Alessi MC; Bonnet JL; Cuisset T
    Platelets; 2016 Dec; 27(8):791-795. PubMed ID: 27275528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Franchi F; Rollini F; Rivas A; Wali M; Briceno M; Agarwal M; Shaikh Z; Nawaz A; Silva G; Been L; Smairat R; Kaufman M; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
    Circulation; 2019 Apr; 139(14):1661-1670. PubMed ID: 30630341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy.
    Shi R; Zhou X; Ji WJ; Zhang YY; Ma YQ; Zhang JQ; Li YM
    Biomed Res Int; 2015; 2015():981841. PubMed ID: 26221610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation at the onset of human endotoxemia is undetectable in vivo.
    Schrottmaier WC; Kral JB; Zeitlinger M; Salzmann M; Jilma B; Assinger A
    Platelets; 2016 Jul; 27(5):479-83. PubMed ID: 26764560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Reticulated Platelets on the Antiplatelet Effect of the Intravenous P2Y12-Receptor Inhibitor Cangrelor.
    Stratz C; Nührenberg T; Valina CM; Löffelhardt N; Mashayekhi K; Ferenc M; Trenk D; Neumann FJ; Hochholzer W
    Thromb Haemost; 2018 Feb; 118(2):362-368. PubMed ID: 29443372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.